Balyasny Asset Management LLC Axogen, Inc. Transaction History

Balyasny Asset Management LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$8.5 - $10.38 $190,026 - $232,055	22,356 New	22,356 $204,000
Q2 2022 Aug 15, 2022	SELL	$6.99 - $10.0 $977,565 - $1.4 Million	-139,852 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$7.26 - $10.7 $1.23 Million - $1.81 Million	-169,375 Reduced 54.77%	139,852 $1.11 Million
Q4 2021 Feb 14, 2022	BUY	$8.8 - $16.0 $943,835 - $1.72 Million	107,254 Added 53.1%	309,227 $2.9 Million
Q3 2021 Nov 15, 2021	SELL	$15.23 - $21.72 $2.33 Million - $3.32 Million	-153,038 Reduced 43.11%	201,973 $3.19 Million
Q2 2021 Aug 16, 2021	BUY	$17.8 - $23.5 $1.88 Million - $2.49 Million	105,760 Added 42.43%	355,011 $7.67 Million
Q1 2021 May 17, 2021	BUY	$17.18 - $22.6 $2.56 Million - $3.36 Million	148,763 Added 148.04%	249,251 $5.05 Million
Q4 2020 Feb 16, 2021	BUY	$11.5 - $17.96 $1.16 Million - $1.8 Million	100,488 New	100,488 $1.8 Million
Q3 2019 Nov 14, 2019	SELL	$12.09 - $20.46 $2.51 Million - $4.25 Million	-207,706 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$18.5 - $25.47 $584,544 - $804,775	31,597 Added 17.94%	207,706 $4.11 Million
Q1 2019 May 15, 2019	BUY	$14.62 - $22.13 $2.57 Million - $3.9 Million	176,109 New	176,109 $3.71 Million
Q4 2018 Feb 14, 2019	SELL	$17.09 - $38.25 $131,610 - $294,563	-7,701 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$34.05 - $55.9 $9.21 Million - $15.1 Million	-270,511 Reduced 97.23%	7,701 $284,000
Q2 2018 Aug 14, 2018	BUY	$36.15 - $52.5 $10.1 Million - $14.6 Million	278,212 New	278,212 $14 Million

163

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $763M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.